Non dilutive funding on phase 2. CEO clearly states on safety and first in human success. He would say if he needed funding on safety and first human trials on the success of preclinical trials. Don’t try and twist my words you troll
Monday the markets are open, so the company has had Wednesday, Thursday, Friday and Monday to announce this fantastic CR of yours apparently. I’ll call you out on Monday and the re post the CEO webinar from a month ago again
NYR Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)